Papillary thyroid cancer screening: Difference between revisions

	Papillary thyroid cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Papillary thyroid cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Papillary thyroid cancer screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Papillary thyroid cancer screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Papillary thyroid cancer screening
CDC on Papillary thyroid cancer screening
Papillary thyroid cancer screening in the news
Blogs on Papillary thyroid cancer screening
Directions to Hospitals Treating Papillary thyroid cancer
Risk calculators and risk factors for Papillary thyroid cancer screening

Revision as of 15:51, 8 August 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

According to the US preventive service task force, screening for papillary thyroid cancer is not recommended.

According to the US preventive service task force, screening for papillary thyroid cancer is not recommended.^[1]

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}} {{Ammu}}
 ==Overview==
+According to the US preventive service task force, screening for papillary thyroid cancer is not recommended.
 ==Screening==
-* It is recommended to do a thyroid examination twice a year since papillary thyroid cancer are usually asymptomatic.
+* According to the US preventive service task force, screening for papillary thyroid cancer is not recommended.<ref name="urlFinal Recommendation Statement: Thyroid Cancer: Screening - US Preventive Services Task Force">{{cite web |url=https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/thyroid-cancer-screening1 |title=Final Recommendation Statement: Thyroid Cancer: Screening - US Preventive Services Task Force |format= |work= |accessdate=}}</ref>
-* RET proto-oncogene expression assessment is also recommended for people with family history of papillary thyroid cancer.
 ==Reference==
 {{Reflist|2}}